The critical role of epigallocatechin gallate in regulating mitochondrial metabolism

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1 Chen Z, Zhu QY, Tsang D, Huang Y. Degradation of green tea catechins in tea drinks. J. Agric. Food Chem. 49(1), 477–482 (2001).
  Medline CASGoogle Scholar
• 2 Oz HS, Chen T, De Villiers WJ. Green tea polyphenols and sulfasalazine have parallel anti-inflammatory properties in colitis models. Front. Immunol. 4, 132 (2013).
  MedlineGoogle Scholar
• 3 Minoda K, Ichikawa T, Katsumata T et al. Influence of the galloyl moiety in tea catechins on binding affinity for human serum albumin. J. Nutr. Sci. Vitaminol. (Tokyo) 56(5), 331–334 (2010).
  Medline CASGoogle Scholar
• 4 Yang XH, Pan Y, Zhan XL, Zhang BL, Guo LL, Jin HM. Epigallocatechin-3-gallate attenuates renal damage by suppressing oxidative stress in diabetic db/db mice. Oxid. Med. Cell. Longev. 2016, 2968462 (2016).
  MedlineGoogle Scholar
• 5 Park SY, Jeong YJ, Kim SH, Jung JY, Kim WJ. Epigallocatechin gallate protects against nitric oxide-induced apoptosis via scavenging ROS and modulating the Bcl-2 family in human dental pulp cells. J. Toxicol. Sci. 38(3), 371–378 (2013).
  Medline CASGoogle Scholar
• 6 Zhu W, Xu J, Ge Y et al. Epigallocatechin-3-gallate (EGCG) protects skin cells from ionizing radiation via heme oxygenase-1 (HO-1) overexpression. J. Radiat. Res. 55(6), 1056–1065 (2014).
  Medline CASGoogle Scholar
• 7 Shi J, Deng H, Pan H, Xu Y, Zhang M. Epigallocatechin-3-gallate attenuates microcystin-LR induced oxidative stress and inflammation in human umbilical vein endothelial cells. Chemosphere 168, 25–31 (2017).
  Medline CASGoogle Scholar
• 8 Zhang Z, Ding Y, Dai X, Wang J, Li Y. Epigallocatechin-3-gallate protects pro-inflammatory cytokine induced injuries in insulin-producing cells through the mitochondrial pathway. Eur. J. Pharmacol. 670(1), 311–316 (2011).
  Medline CASGoogle Scholar
• 9 Luo KW, Wei C, Lung WY et al. EGCG inhibited bladder cancer SW780 cell proliferation and migration both in vitro and in vivo via down-regulation of NF-kappaB and MMP-9. J. Nutr. Biochem. 41, 56–64 (2017).
  Medline CASGoogle Scholar
• 10 Lee S, Razqan GSA, Kwon DH. Antibacterial activity of epigallocatechin-3-gallate (EGCG) and its synergism with β-lactam antibiotics sensitizing carbapenem-associated multidrug resistant clinical isolates of Acinetobacter baumannii. Phytomedicine 24, 49–55 (2017).
  Medline CASGoogle Scholar
• 11 Ohno A, Kataoka S, Ishii Y et al. Evaluation of Camellia sinensis catechins as a swine antimicrobial feed additive that does not cause antibiotic resistance. Microbes Environ. 28(1), 81–86 (2013).
  MedlineGoogle Scholar
• 12 Kuroda Y, Hara Y. Antimutagenic and anticarcinogenic activity of tea polyphenols. Mutat. Res. 436(1), 69–97 (1999).
  Medline CASGoogle Scholar
• 13 Afzal M, Safer AM, Menon M. Green tea polyphenols and their potential role in health and disease. Inflammopharmacology 23(4), 151–161 (2015).
  Medline CASGoogle Scholar
• 14 Kim C-Y, Lee C, Park GH, Jang J-H. Neuroprotective effect of epigallocatechin-3-gallate against beta-amyloid-induced oxidative and nitrosative cell death via augmentation of antioxidant defense capacity. Arch. Pharmacal Res. 32(6), 869–881 (2009).
  Medline CASGoogle Scholar
• 15 Oliveira MRD, Nabavi SF, Daglia M, Rastrelli L, Nabavi SM. Epigallocatechin gallate and mitochondria-a story of life and death. Pharmacol. Res. 104, 70–85 (2016). •• Comprehensive review about the benefits of epigallocatechin gallate (EGCG) in modulating mitochondria.
  Medline CASGoogle Scholar
• 16 Forbes-Hernández TY, Giampieri F, Gasparrini M et al. The effects of bioactive compounds from plant foods on mitochondrial function: a focus on apoptotic mechanisms. Food Chem. Toxicol. 68, 154–182 (2014).
  Medline CASGoogle Scholar
• 17 Teixeira J, Chavarria D, Borges F et al. Dietary polyphenols and mitochondrial function: role in health and disease. Curr. Med. Chem. doi:10.2174/0929867324666170529101810 (2017) (Epub ahead of print).
  MedlineGoogle Scholar
• 18 Uittenbogaard M, Chiaramello A. Mitochondrial biogenesis: a therapeutic target for neurodevelopmental disorders and neurodegenerative diseases. Curr. Pharm. Des. 20(35), 5574–5593 (2014).
  Medline CASGoogle Scholar
• 19 Sae-Tan S, Grove KA, Kennett MJ, Lambert JD. (-)-Epigallocatechin-3-gallate increases the expression of genes related to fat oxidation in the skeletal muscle of high fat-fed mice. Food Funct. 2(2), 111–116 (2011).
  Medline CASGoogle Scholar
• 20 Lee M-S, Shin Y, Jung S, Kim Y. Effects of epigallocatechin-3-gallate on thermogenesis and mitochondrial biogenesis in brown adipose tissues of diet-induced obese mice. Food Nutr. Res. 61(1), 1325307 (2017).
  MedlineGoogle Scholar
• 21 Lee MS, Lee S, Doo M, Kim Y. Green Tea (-)-epigallotocatechin-3-gallate induces PGC-1alpha gene expression in HepG2 cells and 3T3-L1 adipocytes. Prev. Nutr. Food Sci. 21(1), 62–67 (2016).
  Medline CASGoogle Scholar
• 22 Liu HW, Chan YC, Wang MF, Wei CC, Chang SJ. Dietary (-)-epigallocatechin-3-gallate supplementation counteracts aging-associated skeletal muscle insulin resistance and fatty liver in senescence-accelerated mouse. J. Agric. Food Chem. 63(38), 8407–8417 (2015).
  Medline CASGoogle Scholar
• 23 Wang L, Wang Z, Yang K et al. Epigallocatechin gallate reduces slow-twitch muscle fiberformation and mitochondrial biosynthesis in C2C12 cells by repressing AMPK activity and PGC-1α expression. J. Agric. Food Chem. 64(34), 6517–6523 (2016).
  Medline CASGoogle Scholar
• 24 Valenti D, De Bari L, De Rasmo D et al. The polyphenols resveratrol and epigallocatechin-3-gallate restore the severe impairment of mitochondria in hippocampal progenitor cells from a Down syndrome mouse model. Biochim. Biophys. Acta 1862(6), 1093–1104 (2016).
  Medline CASGoogle Scholar
• 25 Valenti D, De Rasmo D, Signorile A et al. Epigallocatechin-3-gallate prevents oxidative phosphorylation deficit and promotes mitochondrial biogenesis in human cells from subjects with Down's syndrome. Biochim. Biophys. Acta 1832(4), 542–552 (2013).
  Medline CASGoogle Scholar
• 26 Zheng J, Ramirez VD. Inhibition of mitochondrial proton F0F1-ATPase/ATP synthase by polyphenolic phytochemicals. Br. J. Pharmacol. 130(5), 1115–1123 (2000).
  Medline CASGoogle Scholar
• 27 Adikesavan G, Vinayagam MM, Abdulrahman LA, Chinnasamy T. (-)-Epigallocatechin-gallate (EGCG) stabilize the mitochondrial enzymes and inhibits the apoptosis in cigarette smoke-induced myocardial dysfunction in rats. Mol. Biol. Rep. 40(12), 6533–6545 (2013).
  Medline CASGoogle Scholar
• 28 Weng Z, Zhou P, Salminen WF et al. Green tea epigallocatechin gallate binds to and inhibits respiratory complexes in swelling but not normal rat hepatic mitochondria. Biochem. Biophys. Res. Commun. 443(3), 1097–1104 (2014). •• Reports about the selective toxicity of EGCG on mitochondria in cancer cells, not in normal cells.
  Medline CASGoogle Scholar
• 29 Karthikeyan B, Harini L, Krishnakumar V, Kannan VR, Sundar K, Kathiresan T. Insights on the involvement of (-)-epigallocatechin gallate in ER stress-mediated apoptosis in age-related macular degeneration. Apoptosis 22(1), 72–85 (2017).
  Medline CASGoogle Scholar
• 30 Ning W, Wang S, Liu D, Fu L, Jin R, Xu A. Potent effects of peracetylated (-)-epigallocatechin-3-gallate against hydrogen peroxide-induced damage in human epidermal melanocytes via attenuation of oxidative stress and apoptosis. Clin. Exp. Dermatol. 41(6), 616–624 (2016).
  Medline CASGoogle Scholar
• 31 Yao Y-F, Liu X, Li W-J et al. (-)-Epigallocatechin-3-gallate alleviates doxorubicin-induced cardiotoxicity in sarcoma 180 tumor-bearing mice. Life Sci. 180, 151–159 (2017).
  Medline CASGoogle Scholar
• 32 Wu CC, Hsu MC, Hsieh CW, Lin JB, Lai PH, Wung BS. Upregulation of heme oxygenase-1 by Epigallocatechin-3-gallate via the phosphatidylinositol 3-kinase/Akt and ERK pathways. Life Sci. 78(25), 2889–2897 (2006).
  Medline CASGoogle Scholar
• 33 Shen K, Feng X, Su R, Xie H, Zhou L, Zheng S. Epigallocatechin 3-gallate ameliorates bile duct ligation induced liver injury in mice by modulation of mitochondrial oxidative stress and inflammation. PLoS ONE 10(5), e0126278 (2015).
  MedlineGoogle Scholar
• 34 Chen Y, Huang L, Zhang H, Diao X, Zhao S, Zhou W. Reduction in autophagy by (-)-epigallocatechin-3-gallate (EGCG): a potential mechanism of prevention of mitochondrial dysfunction after subarachnoid hemorrhage. Mol. Neurobiol. 54(1), 392–405 (2017).
  Medline CASGoogle Scholar
• 35 Liu J, Ames BN. Reducing mitochondrial decay with mitochondrial nutrients to delay and treat cognitive dysfunction, Alzheimer's disease, and Parkinson's disease. Nutr. Neurosci. 8(2), 67–89 (2005).
  Medline CASGoogle Scholar
• 36 Schroeder EK, Kelsey NA, Doyle J et al. Green tea epigallocatechin 3-gallate accumulates in mitochondria and displays a selective antiapoptotic effect against inducers of mitochondrial oxidative stress in neurons. Antioxid. Redox Signal. 11(3), 469–480 (2009). • Reports about the selective accumulation of EGCG in mitochondria.
  Medline CASGoogle Scholar
• 37 Liu S, Sun Z, Chu P et al. EGCG protects against homocysteine-induced human umbilical vein endothelial cells apoptosis by modulating mitochondrial-dependent apoptotic signaling and PI3K/Akt/eNOS signaling pathways. Apoptosis 22(5), 672–680 (2017).
  Medline CASGoogle Scholar
• 38 Shu Z, Yu M, Zeng G, Zhang X, Wu L, Tan X. Epigallocatechin-3-gallate inhibits proliferation of human aortic smooth muscle cells via up-regulating expression of mitofusin 2. Eur. J. Cell Biol. 93(4), 137–144 (2014).
  Medline CASGoogle Scholar
• 39 Liu J, Shen W, Zhao B et al. Targeting mitochondrial biogenesis for preventing and treating insulin resistance in diabetes and obesity: Hope from natural mitochondrial nutrients. Adv. Drug Deliv. Rev. 61(14), 1343–1352 (2009).
  Medline CASGoogle Scholar
• 40 Shankar S, Suthakar G, Srivastava RK. Epigallocatechin-3-gallate inhibits cell cycle and induces apoptosis in pancreatic cancer. Front. Biosci. 12, 5039–5051 (2007).
  Medline CASGoogle Scholar
• 41 Qanungo S, Das M, Haldar S, Basu A. Epigallocatechin-3-gallate induces mitochondrial membrane depolarization and caspase-dependent apoptosis in pancreatic cancer cells. Carcinogenesis 26(5), 958–967 (2005).
  Medline CASGoogle Scholar
• 42 Lee J-H, Jeong Y-J, Lee S-W et al. EGCG induces apoptosis in human laryngeal epidermoid carcinoma Hep2 cells via mitochondria with the release of apoptosis-inducing factor and endonuclease G. Cancer Lett. 290(1), 68–75 (2010).
  Medline CASGoogle Scholar
• 43 Liu J. The effects and mechanisms of mitochondrial nutrient alpha-lipoic acid on improving age-associated mitochondrial and cognitive dysfunction: an overview. Neurochem. Res. 33(1), 194–203 (2008).
  Medline CASGoogle Scholar
• 44 Gerhart-Hines Z, Dominy JE, Blättler SM et al. The cAMP/PKA pathway rapidly activates SIRT1 to promote fatty acid oxidation independently of changes in NAD(+). Mol. Cell 44(6), 851–863 (2011).
  Medline CASGoogle Scholar
• 45 Wu L, Liu H, Li L et al. Mitochondrial pathology in osteoarthritic chondrocytes. Curr. Drug Targets 15(7), 710–719 (2014).
  Medline CASGoogle Scholar
• 46 Santamarina AB, Carvalho-Silva M, Gomes LM et al. Decaffeinated green tea extract rich in epigallocatechin-3-gallate prevents fatty liver disease by increased activities of mitochondrial respiratory chain complexes in diet-induced obesity mice. J. Nutr. Biochem. 26(11), 1348–1356 (2015).
  Medline CASGoogle Scholar
• 47 Castellano-González G, Pichaud N, Ballard JWO, Bessede A, Marcal H, Guillemin GJ. Epigallocatechin-3-gallate induces oxidative phosphorylation by activating cytochrome c oxidase in human cultured neurons and astrocytes. Oncotarget 7(7), 7426–7440 (2016).
  MedlineGoogle Scholar
• 48 Valenti D, De Bari L, Manente GA et al. Negative modulation of mitochondrial oxidative phosphorylation by epigallocatechin-3 gallate leads to growth arrest and apoptosis in human malignant pleural mesothelioma cells. Biochim. Biophys. Acta 1832(12), 2085–2096 (2013).
  Medline CASGoogle Scholar
• 49 Zelko IN, Mariani TJ, Folz RJ. Superoxide dismutase multigene family: a comparison of the CuZn-SOD (SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures, evolution, and expression. Free Radic. Biol. Med. 33(3), 337–349 (2002).
  Medline CASGoogle Scholar
• 50 Chen L, Teng H, Jia Z et al. Intracellular signaling pathways of inflammation modulated by dietary flavonoids: the most recent evidence. Crit. Rev. Food Sci. Nutr. doi:10.1080/10408398.2017.1345853 1–17 (2017) (Epub ahead of print).
  Google Scholar
• 51 Galati G, Lin A, Sultan AM, O'brien PJ. Cellular and in vivo hepatotoxicity caused by green tea phenolic acids and catechins. Free Radic. Biol. Med. 40(4), 570–580 (2006).
  Medline CASGoogle Scholar
• 52 Jiang P, Ray A, Rybak LP, Brenner MJ. Role of STAT1 and oxidative stress in gentamicin-induced hair cell death in organ of corti. Otology & neurotology 37(9), 1449–1456 (2016).
  MedlineGoogle Scholar
• 53 Srividhya R, Zarkovic K, Stroser M, Waeg G, Zarkovic N, Kalaiselvi P. Mitochondrial alterations in aging rat brain: effective role of (-)-epigallo catechin gallate. Int. J. Dev. Neurosci. 27(3), 223–231 (2009).
  Medline CASGoogle Scholar
• 54 Oyama J-I, Shiraki A, Nishikido T et al. EGCG, a green tea catechin, attenuates the progression of heart failure induced by the heart/muscle-specific deletion of MnSOD in mice. J. Cardiol. 69(2), 417–427 (2017).
  MedlineGoogle Scholar
• 55 He Y, Tan D, Mi Y et al. Effect of epigallocatechin-3-gallate on acrylamide-induced oxidative stress and apoptosis in PC12 cells. Hum. Exp. Toxicol. 36(10), 1087–1099 (2017).
  Medline CASGoogle Scholar
• 56 Zhang J, Wang G, Mao Q et al. Glutamate dehydrogenase (GDH) regulates bioenergetics and redox homeostasis in human glioma. Oncotarget 295(10), 799–800 (2016).
  Google Scholar
• 57 Gao Z, Han Y, Hu Y et al. Targeting HO-1 by epigallocatechin-3-gallate reduces contrast-induced renal injury via anti-oxidative stress and anti-inflammation pathways. PLoS ONE 11(2), e0149032 (2016).
  MedlineGoogle Scholar
• 58 Zhang DD, Hannink M. Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress. Mol. Cell. Biol. 23(22), 8137–8151 (2003).
  Medline CASGoogle Scholar
• 59 Gasparrini M, Forbes-Hernandez TY, Giampieri F et al. Anti-inflammatory effect of strawberry extract against LPS-induced stress in RAW 264.7 macrophages. Food Chem. Toxicol. 102, 1–10 (2017).
  Medline CASGoogle Scholar
• 60 Sun W, Liu X, Zhang H et al. Epigallocatechin gallate upregulates NRF2 to prevent diabetic nephropathy via disabling KEAP1. Free Radic. Biol. Med. 108, 840–857 (2017).
  Medline CASGoogle Scholar
• 61 Kucera O, Mezera V, Moravcova A et al. In vitro toxicity of epigallocatechin gallate in rat liver mitochondria and hepatocytes. Oxid. Med. Cell. Longev. 2015, 476180 (2015).
  MedlineGoogle Scholar
• 62 Nakagawa Y, Moldéus P, Moore GA. Relationship between mitochondrial dysfunction and toxicity of propyl gallate in isolated rat hepatocytes. Toxicology 114(2), 135–145 (1996).
  Medline CASGoogle Scholar
• 63 Inacio JDF, Gervazoni L, Canto-Cavalheiro MM, Almeida-Amaral EE. The effect of (-)-epigallocatechin 3-O--gallate in vitro and in vivo in Leishmania braziliensis: involvement of reactive oxygen species as a mechanism of action. PLoS Negl. Trop. Dis. 8(8), e3093 (2014).
  MedlineGoogle Scholar
• 64 Nakagawa H, Hasumi K, Woo J-T, Nagai K, Wachi M. Generation of hydrogen peroxide primarily contributes to the induction of Fe(II)-dependent apoptosis in Jurkat cells by (-)-epigallocatechin gallate. Carcinogenesis 25(9), 1567–1574 (2004).
  Medline CASGoogle Scholar
• 65 Nakagawa H, Wachi M, Woo J-T et al. Fenton reaction is primarily involved in a mechanism of (-)-epigallocatechin-3-gallate to induce osteoclastic cell death. Biochem. Biophys. Res. Commun. 292(1), 94–101 (2002).
  Medline CASGoogle Scholar
• 66 Li G-X, Chen Y-K, Hou Z et al. Pro-oxidative activities and dose–response relationship of (-)-epigallocatechin-3-gallate in the inhibition of lung cancer cell growth: a comparative study in vivo and in vitro. Carcinogenesis 31(5), 902–910 (2010).
  Medline CASGoogle Scholar
• 67 Tao L, Park J-Y, Lambert JD. Differential prooxidative effects of the green tea polyphenol, (-)-epigallocatechin-3-gallate, in normal and oral cancer cells are related to differences in sirtuin 3 signaling. Mol. Nutr. Food Res. 59(2), 203–211 (2015).
  Medline CASGoogle Scholar
• 68 Kil IS, Jung KH, Nam WS, Park J-W. Attenuated mitochondrial NADP+-dependent isocitrate dehydrogenase activity enhances EGCG-induced apoptosis. Biochimie 93(10), 1808–1815 (2011).
  Medline CASGoogle Scholar
• 69 Das A, Banik NL, Ray SK. Flavonoids activated caspases for apoptosis in human glioblastoma T98G and U87MG cells but not in human normal astrocytes. Cancer 116(1), 164–176 (2010).
  Medline CASGoogle Scholar
• 70 Basu A, Haldar S. Combinatorial effect of epigallocatechin-3-gallate and TRAIL on pancreatic cancer cell death. Int. J. Oncol. 34(1), 281–286 (2009).
  Medline CASGoogle Scholar
• 71 Bimonte S, Leongito M, Barbieri A et al. Inhibitory effect of (-)-epigallocatechin-3-gallate and bleomycin on human pancreatic cancer MiaPaca-2 cell growth. Infect. Agent. Cancer 10, 22 (2015).
  MedlineGoogle Scholar
• 72 Kostin SF, Mcdonald DE, Mcfadden DW. Inhibitory effects of (-)-epigallocatechin-3-gallate and pterostilbene on pancreatic cancer growth in vitro. J. Surg. Res. 177(2), 255–262 (2012).
  Medline CASGoogle Scholar
• 73 Pistollato F, Calderón Iglesias R, Ruiz R et al. The use of natural compounds for the targeting and chemoprevention of ovarian cancer. Cancer Lett. 411, 191–200 (2017).
  Medline CASGoogle Scholar
• 74 Pistollato F, Giampieri F, Battino M. The use of plant-derived bioactive compounds to target cancer stem cells and modulate tumor microenvironment. Food Chem. Toxicol. 75, 58–70 (2015). • Comprehensive reviews about the naturally occurring compounds implicated in potential medicinal uses.
  Medline CASGoogle Scholar
• 75 Ran Z-H, Xu Q, Tong J-L, Xiao S-D. Apoptotic effect of Epigallocatechin-3-gallate on the human gastric cancer cell line MKN45 via activation of the mitochondrial pathway. World J. Gastroenterol. 13(31), 4255–4259 (2007).
  Medline CASGoogle Scholar
• 76 Li W, Nie S, Yu Q, Xie M. (-)-Epigallocatechin-3-gallate induces apoptosis of human hepatoma cells by mitochondrial pathways related to reactive oxygen species. J. Agric. Food Chem. 57(15), 6685–6691 (2009).
  Medline CASGoogle Scholar
• 77 Zhang Y, Duan W, Owusu L, Wu D, Xin Y. Epigallocatechin-3-gallate induces the apoptosis of hepatocellular carcinoma LM6 cells but not non-cancerous liver cells. Int. J. Mol. Med. 35(1), 117–124 (2015).
  Medline CASGoogle Scholar
• 78 Singh M, Singh R, Bhui K, Tyagi S, Mahmood Z, Shukla Y. Tea polyphenols induce apoptosis through mitochondrial pathway and by inhibiting nuclear factor-kappaB and Akt activation in human cervical cancer cells. Oncol. Res. 19(6), 245–257 (2011).
  MedlineGoogle Scholar
• 79 Chen N-G, Lu C-C, Lin Y-H et al. Proteomic approaches to study epigallocatechin gallate-provoked apoptosis of TSGH-8301 human urinary bladder carcinoma cells: roles of AKT and heat shock protein 27-modulated intrinsic apoptotic pathways. Oncol. Rep. 26(4), 939–947 (2011).
  Medline CASGoogle Scholar
• 80 Flores-Pérez A, Marchat LA, Sánchez LL et al. Differential proteomic analysis reveals that EGCG inhibits HDGF and activates apoptosis to increase the sensitivity of non-small cells lung cancer to chemotherapy. Proteom. Clin. Appl. 10(2), 172–182 (2016).
  Medline CASGoogle Scholar
• 81 Amin ARMR, Wang D, Zhang H et al. Enhanced anti-tumor activity by the combination of the natural compounds (-)-epigallocatechin-3-gallate and luteolin: potential role of p53. J. Biol. Chem. 285(45), 34557–34565 (2010).
  MedlineGoogle Scholar
• 82 Ranzato E, Martinotti S, Magnelli V et al. Epigallocatechin-3-gallate induces mesothelioma cell death via H2 O2 -dependent T-type Ca2+ channel opening. J. Cell. Mol. Med. 16(11), 2667–2678 (2012).
  Medline CASGoogle Scholar
• 83 Tao L, Forester SC, Lambert JD. The role of the mitochondrial oxidative stress in the cytotoxic effects of the green tea catechin, (-)-epigallocatechin-3-gallate, in oral cells. Mol. Nutr. Food Res. 58(4), 665–676 (2014).
  Medline CASGoogle Scholar
• 84 Satoh M, Takemura Y, Hamada H, Sekido Y, Kubota S. EGCG induces human mesothelioma cell death by inducing reactive oxygen species and autophagy. Cancer Cell Int. 13(1), 19 (2013).
  Medline CASGoogle Scholar
• 85 Weng LX, Wang GH, Yao H, Yu MF, Lin J. Epigallocatechin gallate inhibits the growth of salivary adenoid cystic carcinoma cells via the EGFR/Erk signal transduction pathway and the mitochondria apoptosis pathway. Neoplasma 64(4), 563–570 (2017).
  Medline CASGoogle Scholar
• 86 Kim J-Y, Choi J-Y, Lee H-J et al. The green tea component (-)-epigallocatechin-3-gallate sensitizes primary endothelial cells to arsenite-induced apoptosis by decreasing c-Jun N-terminal kinase-mediated catalase activity. PLoS ONE 10(9), e0138590 (2015).
  MedlineGoogle Scholar
• 87 Yang W-H, Fong Y-C, Lee C-Y et al. Epigallocatechin-3-gallate induces cell apoptosis of human chondrosarcoma cells through apoptosis signal-regulating kinase 1 pathway. J. Cell. Biochem. 112(6), 1601–1611 (2011).
  Medline CASGoogle Scholar
• 88 Gao F, Li M, Liu W-B et al. Epigallocatechin gallate inhibits human tongue carcinoma cells via HK2-mediated glycolysis. Oncol. Rep. 33(3), 1533–1539 (2015).
  Medline CASGoogle Scholar
• 89 Zhou X, Liang L, Zhao Y, Zhang H. Epigallocatechin-3-gallate ameliorates angiotensin ii-induced oxidative stress and apoptosis in human umbilical vein endothelial cells through the activation of Nrf2/Caspase-3 signaling. J. Vasc. Res. 54(5), 299–308 (2017).
  Medline CASGoogle Scholar
• 90 Othman AI, Elkomy MM, El-Missiry MA, Dardor M. Epigallocatechin-3-gallate prevents cardiac apoptosis by modulating the intrinsic apoptotic pathway in isoproterenol-induced myocardial infarction. Eur. J. Pharmacol. 794, 27–36 (2017).
  Medline CASGoogle Scholar
• 91 Qin C-Y, Zhang H-W, Gu J et al. Mitochondrial DNA-induced inflammatory damage contributes to myocardial ischemia reperfusion injury in rats: Cardioprotective role of epigallocatechin. Mol. Med. Report. 16(5), 7569–7576 (2017).
  Medline CASGoogle Scholar
• 92 Yao K, Ye P, Zhang L, Tan J, Tang X, Zhang Y. Epigallocatechin gallate protects against oxidative stress-induced mitochondria-dependent apoptosis in human lens epithelial cells. Mol. Vis. 14, 217–223 (2008).
  Medline CASGoogle Scholar
• 93 Yu N-H, Pei H, Huang Y-P, Li Y-F. (-)-Epigallocatechin-3-Gallate inhibits arsenic-induced inflammation and apoptosis through suppression of oxidative stress in mice. Cell. Physiol. Biochem. 41(5), 1788–1800 (2017).
  Medline CASGoogle Scholar
• 94 Sun M, Qian F, Shen W et al. Mitochondrial nutrients stimulate performance and mitochondrial biogenesis in exhaustively exercised rats. Scand. J. Med. Sci. Sports 22(6), 764–775 (2012).
  Medline CASGoogle Scholar
• 95 Plemel JR, Juzwik CA, Benson CA, Monks M, Harris C, Ploughman M. Over-the-counter anti-oxidant therapies for use in multiple sclerosis: A systematic review. Mult. Scler. 21(12), 1485–1495 (2015).
  Medline CASGoogle Scholar
• 96 Leu JG, Lin CY, Jian JH, Shih CY, Liang YJ. Epigallocatechin-3-gallate combined with alpha lipoic acid attenuates high glucose-induced receptor for advanced glycation end products (RAGE) expression in human embryonic kidney cells. An. Acad. Bras. Cienc. 85(2), 745–752 (2013).
  Medline CASGoogle Scholar
• 97 Chen SA, Chen HM, Yao YD, Hung CF, Tu CS, Liang YJ. Topical treatment with anti-oxidants and Au nanoparticles promote healing of diabetic wound through receptor for advance glycation end-products. Eur. J. Pharm. Sci. 47(5), 875–883 (2012).
  Medline CASGoogle Scholar
• 98 Fatima S, Al-Mohaimeed N, Al-Shaikh Y et al. Combined treatment of epigallocatechin gallate and Coenzyme Q10 attenuates cisplatin-induced nephrotoxicity via suppression of oxidative/nitrosative stress, inflammation and cellular damage. Food Chem. Toxicol. 94, 213–220 (2016).
  Medline CASGoogle Scholar
• 99 Fatima S, Al-Mohaimeed N, Arjumand S, Banu N, Al-Jameil N, Al-Shaikh Y. Effect of pre- and post-combined multidoses of epigallocatechin gallate and coenzyme Q10 on cisplatin-induced oxidative stress in rat kidney. J. Biochem. Mol. Toxicol. 29(2), 91–97 (2015).
  Medline CASGoogle Scholar
• 100 Chi Q, Liu T, Sun Z, Tan S, Li S, Li S. Involvement of mitochondrial pathway in environmental metal pollutant lead-induced apoptosis of chicken liver: perspectives from oxidative stress and energy metabolism. Environ. Sci. Pollut. Res. Int. 24(36), 28121–28131 (2017).
  Medline CASGoogle Scholar
• 101 Wang Y, Su H, Gu Y, Song X, Zhao J. Carcinogenicity of chromium and chemoprevention: a brief update. Onco Targets Ther. 10, 4065–4079 (2017).
  MedlineGoogle Scholar
• 102 Gupta VK, Singh S, Agrawal A, Siddiqi NJ, Sharma B. Phytochemicals mediated remediation of neurotoxicity induced by heavy metals. Biochem. Res. Int. 2015, 534769 (2015).
  MedlineGoogle Scholar
• 103 Han XD, Zhang YY, Wang KL, Huang YP, Yang ZB, Liu Z. The involvement of Nrf2 in the protective effects of (-)-Epigallocatechin-3-gallate (EGCG) on NaAsO2-induced hepatotoxicity. Oncotarget 8(39), 65302–65312 (2017).
  MedlineGoogle Scholar
• 104 Badr El Dine FMM, Nabil IM, Dwedar FI. The effect of Tributyltin on thyroid follicular cells of adult male albino rats and the possible protective role of green tea: a toxicological, histological and biochemical study. Egypt J. Forensic Sci. 7(1), 7 (2017).
  MedlineGoogle Scholar
• 105 Farhan M, Khan HY, Oves M et al. Cancer therapy by catechins involves redox cycling of copper ions and generation of reactive oxygen species. Toxins (Basel) 8(2), 37 (2016).
  MedlineGoogle Scholar
• 106 Romagnolo DF, Daniels KD, Grunwald JT, Ramos SA, Propper CR, Selmin OI. Epigenetics of breast cancer: modifying role of environmental and bioactive food compounds. Mol. Nutr. Food Res. 60(6), 1310–1329 (2016).
  Medline CASGoogle Scholar
• 107 Nelson J, Mcferran NV, Pivato G et al. The 67 kDa laminin receptor: structure, function and role in disease. Biosci. Rep. 28(1), 33–48 (2008).
  Medline CASGoogle Scholar
• 108 Tachibana H. Molecular basis for cancer chemoprevention by green tea polyphenol EGCG. Forum Nutr. 61, 156–169 (2009).
  Medline CASGoogle Scholar
• 109 Kumazoe M, Sugihara K, Tsukamoto S et al. 67-kDa laminin receptor increases cGMP to induce cancer-selective apoptosis. J. Clin. Invest. 123(2), 787–799 (2013).
  Medline CASGoogle Scholar
• 110 Gundimeda U, Mcneill TH, Elhiani AA, Schiffman JE, Hinton DR, Gopalakrishna R. Green tea polyphenols precondition against cell death induced by oxygen-glucose deprivation via stimulation of laminin receptor, generation of reactive oxygen species, and activation of protein kinase Cϵ. J. Biol. Chem. 287(41), 34694–34708 (2012).
  Medline CASGoogle Scholar
• 111 Zhu T-T, Zhang W-F, Luo P et al. Epigallocatechin-3-gallate ameliorates hypoxia-induced pulmonary vascular remodeling by promoting mitofusin-2-mediated mitochondrial fusion. Eur. J. Pharmacol. 809, 42–51 (2017).
  Medline CASGoogle Scholar
• 112 Krupkova O, Handa J, Hlavna M et al. The natural polyphenol epigallocatechin gallate protects intervertebral disc cells from oxidative stress. Oxid. Med. Cell. Longev. 2016, 7031397 (2016).
  MedlineGoogle Scholar
• 113 Kamalden TA, Ji D, Osborne NN. Rotenone-induced death of RGC-5 cells is caspase independent, involves the JNK and p38 pathways and is attenuated by specific green tea flavonoids. Neurochem. Res. 37(5), 1091–1101 (2012).
  Medline CASGoogle Scholar
• 114 Shankar S, Marsh L, Srivastava RK. EGCG inhibits growth of human pancreatic tumors orthotopically implanted in Balb C nude mice through modulation of FKHRL1/FOXO3a and neuropilin. Mol. Cell. Biochem. 372(1–2), 83–94 (2013).
  Medline CASGoogle Scholar
• 115 Devika PT, Stanely Mainzen Prince P. (-)Epigallocatechingallate protects the mitochondria against the deleterious effects of lipids, calcium and adenosine triphosphate in isoproterenol induced myocardial infarcted male Wistar rats. J. Appl. Toxicol. 28(8), 938–944 (2008).
  Medline CASGoogle Scholar
• 116 Pournourmohammadi S, Grimaldi M, Stridh MH et al. Epigallocatechin-3-gallate (EGCG) activates AMPK through the inhibition of glutamate dehydrogenase in muscle and pancreatic β-cells: a potential beneficial effect in the pre-diabetic state? Int. J. Biochem. Cell Biol. 88, 220–225 (2017).
  Medline CASGoogle Scholar
• 117 Roychoudhury S, Agarwal A, Virk G, Cho C-L. Potential role of green tea catechins in the management of oxidative stress-associated infertility. Reprod. Biomed. Online 34(5), 487–498 (2017). •• Comprehensive reviews about the the potential role of EGCG in male and female reproduction and fertility.
  Medline CASGoogle Scholar
• 118 Tsukamoto S, Kumazoe M, Huang Y et al. SphK1 inhibitor potentiates the anti-cancer effect of EGCG on leukaemia cells. Br. J. Haematol. 178(1), 155–158 (2017).
  Medline CASGoogle Scholar
• 119 Bettuzzi S, Brausi M, Rizzi F, Castagnetti G, Peracchia G, Corti A. Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study. Cancer Res. 66(2), 1234–1240 (2006).
  Medline CASGoogle Scholar
• 120 Hao X, Xiao H, Ju J, Lee M-J, Lambert JD, Yang CS. Green tea polyphenols inhibit colorectal tumorigenesis in azoxymethane-treated F344 rats. Nutr. Cancer 69(4), 623–631 (2017).
  Medline CASGoogle Scholar
• 121 Joe AK, Schnoll-Sussman F, Bresalier RS et al. Phase Ib randomized, double-blinded, placebo-controlled, dose escalation study of polyphenon E in patients with Barrett's Esophagus. Cancer Prev. Res. (Phila.) 8(12), 1131–1137 (2015).
  Medline CASGoogle Scholar
• 122 Most J, Timmers S, Warnke I et al. Combined epigallocatechin-3-gallate and resveratrol supplementation for 12 wk increases mitochondrial capacity and fat oxidation, but not insulin sensitivity, in obese humans: a randomized controlled trial. Am. J. Clin. Nutr. 104(1), 215–227 (2016).
  Medline CASGoogle Scholar
• 123 Kumar NB, Pow-Sang J, Egan KM et al. Randomized, placebo-controlled trial of green tea catechins for prostate cancer prevention. Cancer Prev. Res. (Phila.) 8(10), 879–887 (2015).
  Medline CASGoogle Scholar
• 124 Chu C, Deng J, Man Y, Qu Y. Green tea extracts epigallocatechin-3-gallate for different treatments. BioMed. Res. Int. 2017, 5615647 (2017). •• Reviews about the potential applications in different treatments.
  MedlineGoogle Scholar
• 125 Fujiki H, Sueoka E, Rawangkan A, Suganuma M. Human cancer stem cells are a target for cancer prevention using (-)-epigallocatechin gallate. J. Cancer Res. Clin. Oncol. 143(12), 2401–2412 (2017).
  Medline CASGoogle Scholar
• 126 Ludwig A, Lorenz M, Grimbo N et al. The tea flavonoid epigallocatechin-3-gallate reduces cytokine-induced VCAM-1 expression and monocyte adhesion to endothelial cells. Biochem. Biophys. Res. Commun. 316(3), 659–665 (2004).
  Medline CASGoogle Scholar
• 127 Palabiyik SS, Dincer B, Cadirci E et al. A new update for radiocontrast-induced nephropathy aggravated with glycerol in rats: the protective potential of epigallocatechin-3-gallate. Ren. Fail. 39(1), 314–322 (2017).
  Medline CASGoogle Scholar
• 128 Wu YR, Choi HJ, Kang YG, Kim JK, Shin J-W. In vitro study on anti-inflammatory effects of epigallocatechin-3-gallate-loaded nano- and microscale particles. Int. J. Nanomed. 12, 7007–7013 (2017).
  Medline CASGoogle Scholar
• 129 Zhu C, Xu Y, Liu Z-H, Wan X-C, Li D-X, Tai L-L. The anti-hyperuricemic effect of epigallocatechin-3-gallate (EGCG) on hyperuricemic mice. Biomed. Pharmacother. 97, 168–173 (2017).
  MedlineGoogle Scholar